| Year |
Citation |
Score |
| 2023 |
Yakubov E, Ghoochani A, Savaskan N. Editorial: Ferroptosis in malignant brain tumors. Frontiers in Oncology. 13: 1276971. PMID 37841440 DOI: 10.3389/fonc.2023.1276971 |
0.82 |
|
| 2023 |
Yakubov E, Schmid S, Hammer A, Chen D, Dahlmanns JK, Mitrovic I, Zurabashvili L, Savaskan N, Steiner HH, Dahlmanns M. Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema. Frontiers in Oncology. 13: 1176038. PMID 37554158 DOI: 10.3389/fonc.2023.1176038 |
0.82 |
|
| 2023 |
Dahlmanns M, Dahlmanns JK, Savaskan N, Steiner HH, Yakubov E. Glial Glutamate Transporter-Mediated Plasticity: System x/xCT/SLC7A11 and EAAT1/2 in Brain Diseases. Frontiers in Bioscience (Landmark Edition). 28: 57. PMID 37005761 DOI: 10.31083/j.fbl2803057 |
0.613 |
|
| 2021 |
Dahlmanns M, Yakubov E, Dahlmanns JK. Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction. Frontiers in Oncology. 11: 783067. PMID 34926298 DOI: 10.3389/fonc.2021.783067 |
0.402 |
|
| 2021 |
Yakubov E, Eibl T, Hammer A, Holtmannspötter M, Savaskan N, Steiner HH. Therapeutic Potential of Selenium in Glioblastoma. Frontiers in Neuroscience. 15: 666679. PMID 34121995 DOI: 10.3389/fnins.2021.666679 |
0.748 |
|
| 2021 |
Eibl T, Hammer A, Yakubov E, Blechschmidt C, Kalisch A, Steiner HH. Medulloblastoma in adults - reviewing the literature from a surgeon's point of view. Aging. 13. PMID 33497354 DOI: 10.18632/aging.202568 |
0.413 |
|
| 2017 |
Dahlmanns M, Yakubov E, Chen D, Sehm T, Rauh M, Savaskan N, Wrosch JK. Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discovery. 3: 17030. PMID 28835855 DOI: 10.1038/Cddiscovery.2017.30 |
0.725 |
|
| 2016 |
Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyüpoglu IY, Savaskan N. Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency. Oncoscience. 3: 149-55. PMID 27489861 DOI: 10.18632/oncoscience.305 |
0.739 |
|
| 2016 |
Ghoochani A, Schwarz MA, Yakubov E, Engelhorn T, Doerfler A, Buchfelder M, Bucala R, Savaskan NE, Eyüpoglu IY. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis. Oncogene. 35: 6246-6261. PMID 27157615 DOI: 10.1038/Onc.2016.160 |
0.76 |
|
| 2016 |
Fan Z, Bittermann-Rummel P, Yakubov E, Chen D, Broggini T, Sehm T, Hatipoglu-Majernik G, Hock SW, Schwarz M, Engelhorn T, Doerfler A, Buchfelder M, Eyupoglu IY, Savaskan NE. PRG3 induces Ras-dependent oncogenic cooperation in gliomas. Oncotarget. PMID 27058420 DOI: 10.18632/Oncotarget.8592 |
0.647 |
|
| 2015 |
Ghoochani A, Yakubov E, Sehm T, Fan Z, Hock S, Buchfelder M, Eyüpoglu IY, Savaskan NE. A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain. Oncotarget. PMID 26673818 DOI: 10.18632/Oncotarget.6550 |
0.67 |
|
| 2015 |
Choi J, Stradmann-Bellinghausen B, Yakubov E, Savaskan NE, Régnier-Vigouroux A. Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages. Cancer Biology & Therapy. 16: 1205-13. PMID 26047211 DOI: 10.1080/15384047.2015.1056406 |
0.674 |
|
| 2014 |
Yakubov E, Buchfelder M, Eyüpoglu IY, Savaskan NE. Selenium action in neuro-oncology. Biological Trace Element Research. 161: 246-54. PMID 25164034 DOI: 10.1007/S12011-014-0111-8 |
0.759 |
|
| 2012 |
Margalit O, Simon AJ, Yakubov E, Puca R, Yosepovich A, Avivi C, Jacob-Hirsch J, Gelernter I, Harmelin A, Barshack I, Rechavi G, D'Orazi G, Givol D, Amariglio N. Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function. International Journal of Cancer. Journal International Du Cancer. 131: E562-8. PMID 21932419 DOI: 10.1002/Ijc.26441 |
0.386 |
|
| Show low-probability matches. |